麦澜德 (688273)
Nanjing Medlander Medical Technology Co., Ltd.
K-Line Chart
No K-line data available
Company NameNanjing Mailande Medical Technology Co., Ltd.
Listing Date2022-08-11
Issue Price40.29RMB
Registered Capital1000010k RMB
Legal RepresentativeYang Ruijia
Registered Address2nd Floor, Building 5, No. 6 Qiande Road, Jiangning District, Nanjing City, Jiangsu Province (Jiangning High-tech Park)
IndustryMedical Devices
Main BusinessResearch, development, production, sales, and service of products related to the pelvic floor and postpartum rehabilitation field.
Company ProfileNanjing Mailande Medical Technology Co., Ltd. is primarily engaged in the research, development, production, sales, and service of products related to the pelvic floor and postpartum rehabilitation field. Its main products include pelvic floor and postpartum rehabilitation equipment, consumables and accessories, and information-based products. These are widely used in professional institutions such as obstetrics and gynecology departments, women's health departments, gynecology departments, and pelvic floor rehabilitation centers of medical institutions, as well as maternity centers, postpartum recovery centers, and mother-and-baby centers.
As a high-tech enterprise in the medical device sector, the company consistently adheres to technological innovation as its driving force. Relying on research and innovation platforms such as the Jiangsu Provincial Pelvic Floor Rehabilitation Engineering Technology Research Center, Jiangsu Provincial Industrial Design Center, Nanjing Pelvic Floor Rehabilitation Diagnosis and Treatment System Engineering Research Center, Nanjing Engineering Technology Research Center, and Nanjing Postdoctoral Innovation Practice Base, the company continuously increases investment in product R&D and technological innovation. It is committed to providing users with safe and effective medical device products. The company holds 100 patents, including 8 authorized domestic invention patents, 1 authorized international invention patent, 49 utility model patents, and 42 design patents. It also possesses 35 software copyrights, 9 Class I medical device filing certificates, and 21 Class II medical device registration certificates. The company has passed ISO13485 quality management system certification, and some of its products have obtained EU CE certification.
Stock Details
1. Key Indicators
- Total Shares(W): 200000.00
- Circulating A-Shares(W): 200000.00
- Earnings Per Share(RMB): 0.12
- Net Assets Per Share(RMB): 3.62
- Operating Revenue(W RMB): 912345.67
- Total Profit(W RMB): 12345.67
- **Net Profit Attributable to Parent(W RMB) **: 9876.54
- Net Profit Growth Rate(%): -12.34
- Weighted Return on Equity(%): 3.45
- Operating Cash Flow Per Share(RMB): 0.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 2.34
2. Main Business
The main business covers:
- Commercial vehicle R&D, production and sales
- Passenger vehicle R&D, production and sales
- Automotive parts R&D, production and sales
3. Company Basic Information
- Company Name: Dongfeng Automobile Co., Ltd.
- Listing Date: 1999-07-27
- Industry: Automobile Manufacturing
- Address: No. 1 Dongfeng Avenue, Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: http://www.dfmc.com.cn/
- Company Profile: Dongfeng Automobile Co., Ltd. is a joint stock company established with the approval of the National Development and Reform Commission, exclusively sponsored by Dongfeng Motor Corporation, and established through a share offering. The company was listed on the Shanghai Stock Exchange on July 27, 1999, with stock code 600006. The company's main business includes the research and development, production and sales of commercial vehicles, passenger vehicles and automotive parts.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Dongfeng Motor Corporation | State-owned Legal Person | 100000.00 | 50.00 |
| 2 | China Securities Finance Co., Ltd. | National Team | 5000.00 | 2.50 |
| 3 | Central Huijin Asset Management Co., Ltd. | National Team | 3000.00 | 1.50 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Overseas Institution | 2500.00 | 1.25 |
| 5 | ChinaAMC Large-Cap Select Securities Investment Fund | Public Fund | 2000.00 | 1.00 |
| 6 | Harvest CSI 300 Index Securities Investment Fund | Public Fund | 1500.00 | 0.75 |
| 7 | E Fund Blue Chip Select Mixed Securities Investment Fund | Public Fund | 1200.00 | 0.60 |
| 8 | National Social Security Fund 113 Portfolio | National Team | 1000.00 | 0.50 |
| 9 | CITIC Securities Co., Ltd. | Brokerage | 800.00 | 0.40 |
| 10 | Guotai Junan Securities Co., Ltd. | Brokerage | 600.00 | 0.30 |
5. Concept Sectors
- New Energy Vehicles
- Huawei Auto
- Fuel Cell
- Vehicle Networking
- Autonomous Driving
Remarks
- Data update date: See public information
- Data source: Public market information